BioWorld

Aug. 17, 2006

View Archived Issues

CV Therapeutics Brings In $85.5M Via Public Offering

Two days after reporting plans for a public offering, CV Therapeutics Inc. raised $85.5 million, selling more shares than originally intended but at a lower price. (BioWorld Today) Read More

Speedel Gains Rights To SPP200; Abbott Declines

Read More

Sirion Building Ophthalmic Pipeline Via Sytera Merger

Read More

TolerRx Round Gets $35.6M For Type I Diabetes Antibody

Read More

Other News To Note

Read More